At detailed look at China’s increasingly important chemical and pharmaceutical industry. One central aspect is the political and economic situation in China with its strategic and operational implications for Western chemical and pharma companies. Numerous case examples describe how Western companies, such as BASF, Bayer, Bicoll, Ciba, Degussa, DSM and Novartis are managing their market entry in China. The book also analyzes the threat of Western companies in their home markets by Chinese competitors.